Kaufman, John A;
Barnes, Geoffrey D;
Chaer, Rabih A;
Cuschieri, Joseph;
Eberhardt, Robert T;
Johnson, Matthew S;
Kuo, William T;
Murin, Susan;
Patel, Sheena;
Rajasekhar, Anita;
Weinberg, Ido;
Gillespie, David L.
To provide evidence-based recommendations on the use of inferior vena cava (IVC) filters in the treatment of patients with or at substantial risk of venous thromboembolic disease. A multidisciplinary expert panel developed key questions to address in the guideline, and a systematic review of the literatu...
O'Malley, Patrick G;
Arnold, Michael J;
Pharm, Cathy Kelley;
Spacek, Lance;
Buelt, Andrew;
Natarajan, Sundar;
Donahue, Mark P;
Vagichev, Elena;
Ballard-Hernandez, Jennifer;
Logan, Amanda;
Thomas, Lauren;
Ritter, Joan;
Neubauer, Brian E;
Downs, John R.
In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations. The guideline panel de...
Ikizler, T. Alp;
Burrowes, Jerrilynn D;
Byham-Gray, Laura D;
Campbell, Katrina L;
Carrero, Juan-Jesus;
Chan, Winnie;
Fouque, Denis;
Friedman, Allon N;
Ghaddar, Sana;
Goldstein-Fuchs, Jordi D;
Kaysen, George A;
Kopple, Joel D;
Teta, Daniel;
Yee-Moon Wang, Angela;
Cuppari, Lilian.
The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for nutrition in kidney diseases since 1999. Since the publication of the first KDOQI nutrition guideline, there has been a great accumulation of new evidence regarding the managem...
In 2017 the Veterans Administration (VA) and Department of Defense (DOD) launched development of clinical practice guidelines (CPGs) for the diagnosis and treatment of sleep disorders, with the goal of informing and improving patient care. The guideline development process followed GRADE methodology, con...
A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2).[1] The clinical presentation is generally that of a respiratory infection
with a symptom severity ranging from a mild common cold-like illness, to a severe viral ...
Betacoronavirus/patogenicidad,
Infecciones por Coronavirus/diagnóstico por imagen,
Infecciones por Coronavirus/complicaciones,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/diagnóstico por imagen,
Neumonía Viral/tratamiento farmacológico,
Neumonía Viral/complicaciones,
Pandemias/estadística & datos numéricos,
Brote de los Síntomas,
Grupos de Riesgo,
China/epidemiología,
Neumonía Asociada a la Atención Médica/diagnóstico,
Personal de Salud/organización & administración,
Portador Sano/transmisión,
Transmisión Vertical de Enfermedad Infecciosa/prevención & control
The COVID-19 pandemic requires to conscientiously weigh ‘‘timely surgical intervention’’ for colorectal cancer against efforts to conserve hospital resources and protect patients and health care providers. Professional societies provided ad-hoc guidance at the outset of the COVID-19 pandemic on d...
Esta guía de práctica clínica provee recomendaciones informadas por la evidencia para la identificación de marcadores y factores de riesgo de mortalidad de los pacientes críticos, control de la infección, recolección de muestras, cuidado de soporte (ventilatorio y hemodinámico), tratamiento farma...
Atención Dirigida al Paciente/organización & administración,
Infecciones por Coronavirus/complicaciones,
Neumonía Viral/complicaciones,
Betacoronavirus,
Manejo de Atención al Paciente/organización & administración,
Cuidados Críticos,
Unidades de Cuidados Intensivos/organización & administración,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/tratamiento farmacológico,
Antivirales/uso terapéutico,
Factores Inmunológicos/uso terapéutico,
Plasma/inmunología,
Antibacterianos/uso terapéutico
Moores, Lisa K;
Tritschler, Tobias;
Brosnahan, Shari;
Carrier, Marc;
Collen, Jacob F;
Doerschug, Kevin;
Holley, Aaron B;
Jimenez, David;
Gal, Gregoire Le;
Rali, Parth;
Wells, Philip.
Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of...
Thoracic aortic diseases, including disease of the descending thoracic aorta (DTA), are significant causes of death in the United States. Open repair of DTA is a physiologically impactful operation with relatively high rates of mortality, paraplegia, and renal failure. Thoracic endovascular aneurysm repa...
FitzGerald, John D;
Dalbeth, Nicola;
Mikuls, Ted;
Brignardello‐Petersen, Romina;
Guyatt, Gordon;
Abeles, Aryeh M;
Gelber, Allan C;
Harrold, Leslie R;
Khanna, Dinesh;
King, Charles;
Levy, Gerald;
Libbey, Caryn;
Mount, David;
Pillinger, Michael H;
Rosenthal, Ann;
Singh, Jasvinder A;
Sims, James Edward;
Smith, Benjamin J;
Wenger, Neil S;
Bae, Sangmee Sharon;
Danve, Abhijeet;
Khanna, Puja P;
Kim, Seoyoung C;
Lenert, Aleksander;
Poon, Samuel;
Qasim, Anila;
Sehra, Shiv T;
Sharma, Tarun Sudhir Kumar;
Toprover, Michael;
Turgunbaev, Marat;
Zeng, Linan;
Zhang, Mary Ann;
Turner, Amy S;
Neogi, Tuhina.
To provide guidance for the management of gout, including indications for and optimal use of urate- lowering therapy (ULT), treatment of gout ares, and lifestyle and other medication recommendation Fifty- seven population, intervention, comparator, and outcomes questions were developed, followed by a ...
